患者支持计划在支持获得固体瘤恶性瘤治疗的有效性
Lindsay Parker1, Alissa Shaul1, Brian Murphy1
1Evidera, Lexington, MA.
Journal of health economics and outcomes research
|September 4, 2023
概括
患者支持计划有效地改善了获得癌症治疗的机会. 赛尔基尼患者支持 (CPS) 计划成功帮助患者,包括那些患有固体瘤恶性瘤的患者,克服治疗的财务和后勤障碍.
科学领域:
- 在瘤学瘤学.
- 医疗保健服务研究 医疗服务研究
- 药品接入 药品接入 药品接入
背景情况:
- 患者支持计划,通常由制药厂商运营,旨在减少医疗保健准入障碍.
- 这些计划越来越多地帮助有保险和没有保险的患者导航复杂的系统并管理自付费用.
研究的目的:
- 评估制造商赞助的患者支持计划对固体瘤恶性瘤治疗机会的影响.
- 在Celgene患者支持 (CPS) 计划中分析服务利用率,病例结果和患者人口统计.
主要方法:
- 分析社会人口统计学特征,服务使用情况和对处方纳布-帕克利塔塞尔的患者的结果.
- 包括2011年4月至2013年11月在CPS计划中注册的患者随机样本.
- 在患者和病例层面进行评估,按保险类型分层.
主要成果:
- 该研究包括4566名患者 (8134例),其中大多数是女性,65岁以下,并在社区环境中接受治疗.
- 关键的支持服务包括福利调查 (98.5%),免费药物提供 (29.4%),上诉支持 (15.0%) 和共同支付援助 (8.1%).
- 在89.4%的财政支持案例中,Nab-paclitaxel免费提供,而93.3%的符合条件的商业保险患者获得了共同支付援助.
结论:
- 赛尔基尼的患者支持 (CPS) 计划在促进患者获得癌症治疗方面取得了成功.
- 该计划有效地提供了事先授权,上诉和财政援助,使保险和无保险患者受益.
相关概念视频
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:27Tumor Immunotherapy
555
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
555
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
01:21Cancer Survival Analysis
381
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381